WASHINGTON (TND) — CVS Health said Thursday it will be pulling some over-the-counter medicines in light of a Food and Drug Administration vote against the effectiveness of a certain ingredient.
The statement said CVS will continue the sale of other “oral cough and cold products” to “meet consumer needs."
“We are aware of the FDA Advisory Committee’s position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations,” the statement continued.
